title: Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro.
abstract: Granulocyte colony-stimulating factor (G-CSF) has important direct and priming effects on different functions of normal mature polymorphonuclear leukocytes (PMNL). Previous study has shown an alteration in respiratory burst and bactericidal activities of PMNL harvested from children with cancer treated with chemotherapy. The present study evaluates the possibility that recombinant human (rh) G-CSF could correct these defective functions in vitro. Free radical formation in defective PMNL was enhanced by rhG-CSF to a level similar to that found in normal PMNL primed by rhG-CSF. The defective bactericidal activity against Escherichia coli and Staphylococcus aureus was also corrected. This bactericidal activity was not different from that observed in normal PMNL primed by rhG-CSF. In conclusion, correction of the altered free radical-formation pathway by rhG-CSF in these cells contributed to the restoration of normal bactericidal activity against both gram-positive and gram-negative microorganisms.
authors.affiliation: Department of Hematology, Hôpital Universitaire Saint-Pierre, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Lejeune
authors.forename: E
authors.initials: E
authors.lastname: Sariban
authors.forename: B
authors.initials: B
authors.lastname: Cantinieaux
authors.forename: A
authors.initials: A
authors.lastname: Ferster
authors.forename: C
authors.initials: C
authors.lastname: Devalck
authors.forename: P
authors.initials: P
authors.lastname: Fondu
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001770:Blood Bactericidal Activity / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D013211:Staphylococcus aureus / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor